You are here

breast cancer

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction

Clinical Trials Arena

Mon, 09/16/24 - 10:56 am

clinical trials

Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap

Fierce Biotech

Mon, 09/9/24 - 11:01 am

Relay Therapeutics

clinical trials

Avenzo and Gilead partner for breast cancer combination regimen trial

Clinical Trials Arena

Wed, 09/4/24 - 11:39 am

Avenzo Therapeutics

Gilead Sciences

clinical trials

EU starts review of Enhertu in HER2-ultra-low breast cancer

Pharmaphorum

Mon, 08/19/24 - 09:56 am

IceCure presents hat-trick of positive trial data for cryoablation device

Clinical Trials Arena

Mon, 07/22/24 - 06:45 pm

IceCure Medical

Exscientia pays $20M for full control of CDK7 drug, plans breast cancer combo trial

Fierce Biotech

Thu, 07/18/24 - 11:10 am

ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer

Fierce Pharma

Sun, 06/2/24 - 02:46 pm

Pfizer, Arvinas Post Upbeat Data From Breast Cancer Study

NASDAQ

Thu, 05/16/24 - 09:54 pm

clinical trials

AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial

Clinical Trials Arena

Mon, 04/29/24 - 11:12 am

HER2-low breast cancer

Breast Cancer Detection Drug-Device System Nabs FDA Approval

Medical Devices and Diagnostics Industry

Mon, 04/22/24 - 05:51 pm

optical imaging

QT imaging’s breast imaging system proves as effective as mammography

Clinical Trials Arena

Wed, 04/17/24 - 11:15 am

Breast Acoustic

Novartis pauses enrollment in some Kisqali trials to fix manufacturing

BioPharma Dive

Wed, 04/10/24 - 05:28 pm

drug manufacturing

clinical trials

AZ, Daiichi Sankyo file Dato-DXd for second indication

Pharmaphorum

Tue, 04/2/24 - 11:31 am

FDA panel backs Lumicell’s agent for breast cancer imaging tool

Medtech Dive

Mon, 03/11/24 - 11:56 am

Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities

Fierce Biotech

Mon, 02/5/24 - 10:23 am

American Cancer Society

clinical trials

pharma marketing

prostate cancer

BioNTech challenges AstraZeneca with breast cancer precision drug trial

Reuters

Mon, 01/22/24 - 11:15 am

Duality Biologics

clinical trials

HER2+ breast cancer

Seagen seeks new approval for Tukysa in HER2+ breast cancer

Clinical Trials Arena

Mon, 12/18/23 - 11:32 am

HER2+ breast cancer

Novartis gears up for label expansion for Kisqali with Phase III results

Clinical Trials Arena

Mon, 12/11/23 - 11:18 am

clinical trials

early breast cancer

Roche reports positive Phase III data for breast cancer therapy

Clinical Trials Arena

Tue, 12/5/23 - 09:56 am

clinical trials

metastatic breast cancer

AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment

BioSpace

Sun, 11/19/23 - 09:36 pm

Pages